tiprankstipranks
Company Announcements

Boundless Bio Appoints New CFO Following Departure

Don't Miss our Black Friday Offers:

Boundless Bio Inc. ( (BOLD) ) has issued an update.

Boundless Bio, Inc. has announced the departure of CFO Jami Rubin, who stepped down effective October 11, 2024, entitling her to severance benefits under the company’s plan. Succeeding her, David Hinkle, previously the Senior Vice President of Finance, has been appointed as the new CFO, Treasurer, and principal accounting officer. Hinkle brings extensive experience from previous roles at Crinetics Pharmaceuticals and other biotech firms.

For an in-depth examination of BOLD stock, go to TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskBoundless Bio’s Q3 2024: Advancing Cancer Therapies
TheFlyBoundless Bio reports Q3 EPS (74c), consensus (75c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App